This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bone Metabolism Therapeutics Market To 2018 - Hyperparathyroidism Sector To Decline In The Absence Of New Product Launches And Increased Generic Erosion For Zemplar, Hectorol And Sensipar

8.2.1 Summary of Co-development Deals 101

8.3 Licensing Deals 102

8.3.1 Summary of Licensing Deals 103

9 Bone Metabolism Therapeutics Market to 2018 - Appendix 105

9.1 Market Definitions 105

9.2 Abbreviations 105

9.3 Sources 106

9.4 Research Methodology 106

9.4.1 Coverage 106

9.4.2 Secondary Research 107

9.4.3 Primary Research 107

9.5 Therapeutic Landscape 108

9.5.1 Epidemiology-based Forecasting 108

9.5.2 Market Size by Geography 110

9.6 Geographical Landscape 111

9.7 Pipeline Analysis 111

9.8 Competitive Landscape 111

9.8.1 Expert Panel Validation 111

9.9 Contact Us 111

9.10 Disclaimer 112

 

 

 

List of Tables

 

Table 1: Bone Metabolism Therapeutics Market, Global, Revenue ($bn), 2002-2010 12

Table 2: Bone Metabolism Therapeutics Market, Global, Revenue Forecasts ($bn), 2010-2018 12

Table 3: Bone Metabolism Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 13

Table 4: Bone Metabolism Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2018 13

Table 5: Bone Metabolism Therapeutics Market, Global, Treatment Usage Patterns (millions), 2002-2010 14

Table 6: Bone Metabolism Therapeutics Market, Global, Treatment Usage Patterns (millions), 2010-2018 15

Table 7: Bone Metabolism Therapeutics Market, Global, Revenue Analysis by Geography ($bn), 2002-2010 17

Table 8: Bone Metabolism Therapeutics Market, Global, Revenue Analysis by Geography ($bn), 2010-2018 17

Table 9: Bone Metabolism Therapeutics Market, The US, Revenue ($bn), 2002-2010 18

Table 10: Bone Metabolism Therapeutics Market, The US, Revenue Forecasts ($bn), 2010-2018 18

Table 11: Bone Metabolism Therapeutics Market, The US, Annual Cost of Treatment ($), 2002-2010 19

Table 12: Bone Metabolism Therapeutics Market, The US, Annual Cost of Treatment ($), 2010-2018 19

Table 13: Bone Metabolism Therapeutics Market, The US, Treatment Usage Patterns (millions), 2002-2010 20

Table 14: Bone Metabolism Therapeutics Market, The US, Treatment Usage Patterns (millions), 2010-2018 21

Table 15: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Revenue ($bn), 2002-2010 22

Table 16: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Revenue Forecasts ($bn), 2010-2018 22

Table 17: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, by Geography, Revenue ($bn), 2002-2010 23

Table 18: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, by Geography, Revenue Forecasts ($bn), 2010-2018 23

Table 19: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Annual Cost of Treatment ($), 2002-2010 24

Table 20: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Annual Cost of Treatment ($), 2010-2018 24

Table 21: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Treatment Usage Patterns (millions), 2002-2010 25

Table 22: Bone Metabolism Therapeutics Market, Top Five Countries of Europe, Treatment Usage Patterns (millions), 2010-2018 26

Table 23: Bone Metabolism Therapeutics Market, Japan, Revenue ($bn), 2002-2010 27

Table 24: Bone Metabolism Therapeutics Market, Japan, Revenue Forecasts ($bn), 2010-2018 27

Table 25: Bone Metabolism Therapeutics Market, Japan, Annual Cost of Treatment ($), 2002-2010 28

Table 26: Bone Metabolism Therapeutics Market, Japan, Annual Cost of Treatment ($), 2010-2018 28

Table 27: Bone Metabolism Therapeutics Market, Japan, Treatment Usage Patterns (millions), 2002-2010 29

Table 28: Bone Metabolism Therapeutics Market, Japan, Treatment Usage Patterns (millions), 2010-2018 30

Table 29: Osteoporosis Therapeutics Market, Global, Revenue ($bn), 2002-2010 31

5 of 10

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,985.61 +78.99 0.47%
S&P 500 1,972.83 +9.12 0.46%
NASDAQ 4,419.0340 +27.5710 0.63%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs